Response of extrapancreatic glucagon to glycemic changes. 1980

A Ohneda, and T Kobayashi, and J Nihei

Since the secretion of pancreatic glucagon is largely influenced by changes in the blood glucose level, the response of extrapancreatic glucagon to glycemic changes was investigated in man and dogs. Neither insulin-induced hypoglycemia nor arginine infusion caused a rise in plasma glucagon in two patients with total pancreatectomy, but plasma glucagon increased transiently in one of the two patients after oral glucose load. Glucose-induced hyperglycemia did not alter plasma glucagon in the portal vein in a group of 4 depancreatized dogs. When blood glucose fell lower than 50 mg/100 ml after insulin infusion in a group of 7 depancreatized dogs, plasma glucagon in the portal vein did not increase significantly. The administration of 2-deoxyglucose did not cause any changes in plasma glucagon in the portal vein in a group of 5 pancreatectomized dogs. After the ligation of the hepatic artery, blood glucose decreased gradually in a group of 5 pancreatectomized dogs with portacaval shunt, but plasma glucagon in the vena cava was not altered significantly. It is concluded from the present study that regulation of extrapancreatic glucagon differs from that of pancreatic glucagon.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011167 Portacaval Shunt, Surgical Surgical portasystemic shunt between the portal vein and inferior vena cava. Eck Fistula,Portacaval Anastomosis,Portacaval Shunt,Shunt, Surgical Portacaval,Surgical Portacaval Shunt,Anastomoses, Portacaval,Anastomosis, Portacaval,Fistula, Eck,Portacaval Anastomoses,Portacaval Shunts,Portacaval Shunts, Surgical,Shunt, Portacaval,Shunts, Portacaval,Shunts, Surgical Portacaval,Surgical Portacaval Shunts
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Ohneda, and T Kobayashi, and J Nihei
March 1978, The Journal of clinical endocrinology and metabolism,
A Ohneda, and T Kobayashi, and J Nihei
January 2019, Diabetes research and clinical practice,
A Ohneda, and T Kobayashi, and J Nihei
November 1976, Metabolism: clinical and experimental,
A Ohneda, and T Kobayashi, and J Nihei
February 2016, Nature reviews. Endocrinology,
A Ohneda, and T Kobayashi, and J Nihei
March 2016, Diabetes,
A Ohneda, and T Kobayashi, and J Nihei
January 1980, Annales d'endocrinologie,
A Ohneda, and T Kobayashi, and J Nihei
January 1978, Journees annuelles de diabetologie de l'Hotel-Dieu,
A Ohneda, and T Kobayashi, and J Nihei
January 1970, Acta isotopica,
A Ohneda, and T Kobayashi, and J Nihei
February 1980, The Journal of pediatrics,
Copied contents to your clipboard!